Back
GSK PLC 10K Form
Sell
37
GLAXF
GSK PLC
Last Price:
$16.90
Seasonality Move:
-0.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GLAXF News And Ratings
See the #1 stock for the next 7 days that we like better than GLAXF
GLAXF Financial Statistics
Sales & Book Value
| Annual Sales: | $37.7B |
|---|---|
| Cash Flow: | $1.7B |
| Price / Cash Flow: | 11.51 |
| Annual Sales: | $4.59 |
| Price / Book: | 3.68 |
Profitability
| EPS (TTM): | 0.76910 |
|---|---|
| Net Income (TTM): | $3.2B |
| Gross Margin: | $27.1B |
| Return on Equity: | 18.89% |
| Return on Assets: | 4.23% |
GSK PLC Earnings Forecast
Key GSK PLC Financial Ratios
-
The Gross Profit Margin over the past 29 years for GLAXF is 71.76%.
-
The Selling, General & Administrative Expenses for GLAXF have been equal to 30.95% of Gross Profit Margin.
-
The Research & Development expenses have been 20.52% of Revenue.
-
The Interest Expense is 14.71% of Operating Income.
-
The Net Earning history of GLAXF is 16.25% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 23 years.
GSK PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | GLAXF |
| Website: | gsk.com |
Debt
| Debt-to-Equity Ratio: | 1.15 |
|---|---|
| Current Ratio: | 0.81 |
| Quick Ratio: | 0.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.33 |
|---|---|
| Forward P/E Ratio: | 0 |